- Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
-
Garnero M, Fabbri S, Gemelli C, Benedetti , Mancardi G, Schenone A, Grandis M
- KMID: 2399605
- J Clin Neurol.
- 2018 Jan;14(1):98-99.
- doi: 10.3988/jcn.2018.14.1.98
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
